Structured diagnosis and timely treatment of dual diagnosis: effect on the retention rate in outpatient treatment for substance use disorders

References

• Alfonzo-Bello, L., Szerman, N., Marín-Navarrete, R., Arribas-Ibar, E., Pérez-Lopez, A., Babín, F., & Medina-Mora, M. E. (2017). Ibero-American initiative for dual disorders to improve public treatment programs. Salud mental, 40(6), 249–255. https://doi.org/10.17711/SM.0185-3325.2017.032
   Web of Science ®Google Scholar
• Barrowclough, C., Haddock, G., Beardmore, R., Conrod, P., Craig, T., Davies, L., Dunn, G., Lewis, S., Moring, J., Tarrier, N., & Wykes, T. (2009). Evaluating integrated MI and CBT for people with psychosis and substance misuse: Recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviors, 34(10), 859–866. https://doi.org/10.1016/j.addbeh.2009.03.007
   PubMed Web of Science ®Google Scholar
• Bogenschutz, M. P., & Siegfreid, S. L. (1998). Factors affecting engagement of dual diagnosis patients in outpatient treatment. Psychiatric Services, 49(10), 1350–1352. https://doi.org/10.1176/ps.49.10.1350
   PubMed Web of Science ®Google Scholar
• Broome, K. M., Simpson, D. D., & Joe, G. W. (1999). Patient and program attributes related to treatment process indicators in DATOS. Drug and Alcohol Dependence, 57(2), 127–135. https://doi.org/10.1016/S0376-8716(99)00080-0
   PubMed Web of Science ®Google Scholar
• Brorson, H. H., Ajo Arnevik, E., Rand-Hendriksen, K., & Duckert, F. (2013). Drop-out from addiction treatment: A systematic review of risk factors. Clinical Psychology Review, 33(8), 1010–1024. https://doi.org/10.1016/j.cpr.2013.07.007
   PubMed Web of Science ®Google Scholar
• Cacciola, J. S., Pecoraro, A., & Alterman, A. I. (2008). Development of ASI psychiatric severity cut-off scores to identify co-occurring psychiatric disorders. International Journal of Mental Health and Addiction, 6(1), 77–92. https://doi.org/10.1007/s11469-007-9103-7
   Google Scholar
• Cridland, E. K., Deane, F. P., Hsu, C.-I., & Kelly, P. J. (2012). A comparison of treatment outcomes for individuals with substance use disorder alone and individuals with probable dual diagnosis. International Journal of Mental Health and Addiction, 10(5), 670–683. https://doi.org/10.1007/s11469-011-9364-z
   Web of Science ®Google Scholar
• Franey, C., & Quirk, A. (1996). Dual diagnosis: Executive summary number 51. London. Centre for Research on Drugs and Health Behaviour Imperial College School of Medicine, University of London.
   Google Scholar
• Friedmann, P. D., Lemon, S. C., Anderson, B. J., & Stein, M. D. (2003). Predictors of follow-up health status in the drug abuse treatment outcome study (DATOS). Drug and Alcohol Dependence, 69(3), 243–251. https://doi.org/10.1016/S0376-8716(02)00323-X
   PubMed Web of Science ®Google Scholar
• Grella, C. E., & Gilmore, J. (2002). Improving service delivery to the dually diagnosed in Los Angeles County. Journal of Substance Abuse Treatment, 23(2), 115–122. https://doi.org/10.1016/S0740-5472(02)00254-4
   PubMed Web of Science ®Google Scholar
• Grella, C. E., & Joshi, V. (1999). Gender differences in drug treatment careers among clients in the national drug abuse treatment outcome study. The American Journal of Drug and Alcohol Abuse, 25(3), 385–406. https://doi.org/10.1081/ADA-100101868
   PubMed Web of Science ®Google Scholar
• Herbeck, D. M., Fitek, D. J., Svikis, D. S., Montoya, I. D., Marcus, S. C., & West, J. C. (2005). Treatment compliance in patients with comorbid psychiatric and substance use disorders. American Journal on Addictions, 14(3), 195–207. https://doi.org/10.1080/10550490590949488
   PubMed Web of Science ®Google Scholar
• Hubbard, R. L., Marsden, M. E., Rachal, J. V., Harwood, H. J., Cavanaugh, E. R., & Ginzburg, H. M. (1989). Drug abuse treatment: A national study of effectiveness. National Institute of Justice.
   Google Scholar
• Institute for Health Metrics and Evaluation. (2018). Global burden of disease study 2017 (GBD 2017) data resources. GBD Results Tools.
   Google Scholar
• Kessler, R. C. (2004). The epidemiology of dual diagnosis. Biological Psychiatry, 56(10), 730–737. https://doi.org/10.1016/j.biopsych.2004.06.034
   PubMed Web of Science ®Google Scholar
• Lappan, S. N., Brown, A. W., & Hendricks, P. S. (2020). Dropout rates of in‐person psychosocial substance use disorder treatments: A systematic review and meta‐analysis. Addiction, 115(2), 201–217. https://doi.org/10.1111/add.14793
   PubMed Web of Science ®Google Scholar
• Lima-Castro, S., Carballo-Crespo, J., & Rueda, F. (2017). Variables de la relación terapéutica asociadas con la asistencia a programas de tratamientos de conductas adictivas. Maskana, 8(, 25–35. Available at: https://publicaciones.ucuenca.edu.ec/ojs/index.php/maskana/article/view/1874 (Accessed: 25 January 2021)
   Google Scholar
• Lingford-Hughes, A., Welch, S., Peters, L., & Nutt, D. J. (2012). BAP updated guidelines: Evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: Recommendations from BAP. Journal of Psychopharmacology, 26(7), 899–952. https://doi.org/10.1177/0269881112444324
   PubMed Web of Science ®Google Scholar
• Magill, M., & Ray, L. A. (2009). Cognitive-behavioral treatment with adult alcohol and illicit drug users: A meta-analysis of randomized controlled trials. Journal of Studies on Alcohol and Drugs, 70(4), 516–527. https://doi.org/10.15288/jsad.2009.70.516
   PubMed Web of Science ®Google Scholar
• Martínez-González, J. M., Vilar-López, R., & Verdejo-García, A. (2018). Efectividad a Largo Plazo de la Terapia de Grupo Cognitivo-conductual del Alcoholismo: Impacto de la Patología Dual en el Resultado del Tratamiento. Clínica y Salud, 29(1), 1–8. https://doi.org/10.5093/clysa2018a1
   Google Scholar
• McHugh, R. K., Murray, H. W., Hearon, B. A., Pratt, E. M., Pollack, M. H., Safren, S. A., & Otto, M. W. (2013). Predictors of dropout from psychosocial treatment in opioid-dependent outpatients: Predictors of treatment dropout. The American Journal on Addictions, 22(1), 18–22. https://doi.org/10.1111/j.1521-0391.2013.00317.x
   PubMed Web of Science ®Google Scholar
• Minkoff, K. (2001). Best practices: Developing standards of care for individuals with co-occurring psychiatric and substance use disorders. Psychiatric Services, 52(5), 597–599. https://doi.org/10.1176/appi.ps.52.5.597
   PubMed Web of Science ®Google Scholar
• Pristach, C. A., & Smith, C. M. (1999). Attitudes towards alcoholics anonymous by dually diagnosed psychiatric inpatients. Journal of Addictive Diseases, 18(3), 69–76. https://doi.org/10.1300/J069v18n03_07
   PubMed Web of Science ®Google Scholar
• Rehm, J., & Monteiro, M. (2005). Alcohol consumption and burden of disease in the Americas: Implications for alcohol policy. Revista Panamericana de Salud Pública, 18(4–5), 241–248. https://doi.org/10.1590/S1020-49892005000900003
   PubMed Web of Science ®Google Scholar
• Renner, J. A. (2007). Training psychiatrists to treat dual diagnosis patients. Journal of Dual Diagnosis, 3(2), 125–136. https://doi.org/10.1300/J374v03n02_14
   Google Scholar
• Rojas, E., Real, T., García-Silberman, S., & Medina-Mora, M. E. (2011). Revisión sistemática sobre tratamiento de adicciones en México. Salud mental, 34(4), 351–365. Available at: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0185-33252011000400008 (Accessed: 24 January 2021)
   Google Scholar
• Roncero, C., Szerman, N., Teran, A., Pino, C., Vazquez, J. M., Velasco, E., Garcia Dorado, M., & Casas, M. (2016). Professionals’ perception on the management of patients with dual disorders. Patient Preference and Adherence, 10, 1855–1868. doi:10.2147/PPA.S108678
   Google Scholar
• Santonja-Gómez, F.-J., Sánchez-Hervás, E., Secades-Villa, R., Zacarés-Romaguera, F., García-Rodríguez, O., & García-Fernández, G. (2010). Pretreatment characteristics as predictors of retention in cocaine-dependent outpatients. Addictive Disorders & Their Treatment, 9(2), 93–98. https://doi.org/10.1097/ADT.0b013e3181bff7ec
   Google Scholar
• Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., & Dunbar, G. C. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry, 59 \(Suppl 20), 22–33. Available at: https://pubmed.ncbi.nlm.nih.gov/9881538/ (Accessed: 22 January 2021)
   Google Scholar
• Simpson, D. D., Joe, G. W., & Brown, B. S. (1997). Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors, 11(4), 294–307. https://doi.org/10.1037/0893-164X.11.4.294
   Web of Science ®Google Scholar
• Simpson, D. D., & Sells, S. B. (1982). Effectiveness of treatment for drug abuse: An overview of the DARP research program. Advances in Alcohol & Substance Abuse, 2(1), 7–29. https://doi.org/10.1300/J251v02n01_02
   Google Scholar
• Szerman, N., Martinez-Raga, J., Peris, L., Roncero, C., Basurte, I., Vega, P., Ruiz, P., & Casas, M. (2013). Rethinking Dual Disorders/Pathology. Addictive Disorders & Their Treatment, 12(1), 1–10. https://doi.org/10.1097/ADT.0b013e31826e7b6a
   Google Scholar
• Tate, S. R., Mrnak-Meyer, J., Shriver, C. L., Atkinson, J. H., Robinson, S. K., & Brown, S. A. (2011). Predictors of treatment retention for substance-dependent adults with co-occurring depression: Treatment retention. The American Journal on Addictions, 20(4), 357–365. https://doi.org/10.1111/j.1521-0391.2011.00137.x
   PubMed Web of Science ®Google Scholar
• Tsuang, J. W., Fong, T. W., & Ho, A. P. (2003). Dual Diagnosis and Treatment Compliance. Psychiatric Services, 54(4), 576. https://doi.org/10.1176/appi.ps.54.4.576
   PubMed Web of Science ®Google Scholar
• Veach, L. J., Remley, T. P., Kippers, S. M., & Sorg, J. D. (2000). Retention predictors related to intensive outpatient Programs for substance use disorders. The American Journal of Drug and Alcohol Abuse, 26(3), 417–428. https://doi.org/10.1081/ADA-100100253
   PubMed Web of Science ®Google Scholar
• Villatoro-Velázquez, J. A., Resendiz-Escobar, E., Mujica-Salazar, A., Bretón-Cirett, M., Cañas-Martínez, V., Soto-Hernández, I., Fregoso-Ito, D., Fleiz-Bautista, C., Medina-Mora M. E., Gutiérrez-Reyes, J., Franco-Núñez, A., Romero-Martínez, M. & Mendoza-Alvarado, L. (2017). Encuesta Nacional de Consumo de Drogas, Alcohol y Tabaco 2016–2017: Reporte de Drogas. México: INPRFM
   Google Scholar
• Windsor, L. C., Jemal, A., & Alessi, E. J. (2015). Cognitive behavioral therapy: A meta-analysis of race and substance use outcomes. Cultural Diversity and Ethnic Minority Psychology, 21(2), 300–313. https://doi.org/10.1037/a0037929
   PubMed Web of Science ®Google Scholar
• World Drug Report 2020. (2020). United nations : World drug report 2020. Retrieved January 22, 2021, from //wdr.unodc.org/wdr2020/en/index.html
   Google Scholar
• Wüsthoff, L. E., Waal, H., & Gråwe, R. W. (2014). The effectiveness of integrated treatment in patients with substance use disorders co-occurring with anxiety and/or depression - a group randomized trial. BMC Psychiatry, 14(1), 67. https://doi.org/10.1186/1471-244X-14-67
   PubMedGoogle Scholar